Elevance Health, Inc.

Elevance Health, Inc.

Healthcare Plans Healthcare Indianapolis, IN, United States ELV (NYQ)
Quarter: Q4 2025 Reported: October 21, 2025 Sentiment: Neutral

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Analysis Summary

The provided text is a regulatory filing excerpt, specifically detailing Item 2.02 and 9.01, along with a 'FORWARD-LOOKING STATEMENTS' section. It explicitly states that a Press Release dated October 21, 2025, reporting financial results for the quarter ended September 30, 2025 (Q3 2025), is an exhibit. However, the document itself does not contain any actual financial performance data for Q4 2025, nor does it include revenue figures, net income, EPS, or any forward guidance. There are no strategic initiatives, business segment analyses, management commentary, or analyst Q&A highlights present. The primary content is a detailed list of general risk factors pertinent to the healthcare industry and Elevance Health, including trends in healthcare costs, regulatory changes, cyber-attacks, economic conditions, competitive pressures, and risks associated with government programs like Medicare and Medicaid. Without the actual earnings report or call transcript, a comprehensive financial analysis is not possible.

Key Highlights

  • The document is a legal disclosure, not an earnings call transcript.
  • No Q4 2025 financial results, guidance, or performance metrics are provided.
  • It references a press release for Q3 2025 financial results as an exhibit.
  • Contains extensive boilerplate language regarding forward-looking statements.
  • Includes a detailed list of general risk factors for the company and the healthcare industry.
  • Lacks management commentary, strategic updates, or analyst Q&A.

Financial Metrics

eps
N/A
YoY: N/A
revenue
N/A N/A
YoY: N/A
guidance
net income
N/A N/A
YoY: N/A

Stock Performance (90 Days)

Data through Dec 26, 2025
Layoff Events
Earnings Calls

Positive Signals

  • No specific positive indicators mentioned in this legal boilerplate.

Risks & Concerns

  • Trends in healthcare costs and utilization rates.
  • Impact of new or changes in existing federal, state, and international healthcare regulations.
  • Impact of cyber-attacks or other privacy/data security incidents.
  • Changes in economic and market conditions.
  • Risks and uncertainties regarding Medicare and Medicaid programs.

Full Transcript

Recent Elevance Health, Inc. News

Stock Price

$349.88
ELV· NYQ
1.92% day

Company Info

Industry
Healthcare Plans
Sector
Healthcare
Headquarters
Indianapolis, IN, United States
CEO
Ms. Gail Koziara Boudreaux
Employees
104,200
View Company Profile

Layoff Stats

Layoff Events
0
Total Affected
0

Recent Layoffs

No canonical layoff events recorded for this company.

Financials

Market Cap $78.79B
Revenue $194.82B
Profit Margin 2.8%
Cash $36.22B
Debt $32.10B